Director General Updates Hadassah Global Leaders About COVID-19

Wednesday, Apr 8 2020

Prof. Zeev Rotstein

As part of its campaign, “COVID-19, Together We Live,” Hadassah International held a global leadership zoom call, April 6, giving Hadassah Medical Center Director General Prof. Zeev Rotstein a vehicle to update HI supporters.

Prof. Rotstein emphasized that Hadassah is a pioneer on the front lines of the war against the coronavirus, with over 100 COVID-19 patients now at the hospital. Hadassah, he reported, is the first and only hospital in the country to test all its health care workers for COVID-19. Each health care worker is tested every five days.

After the first round of testing, 1.5 percent tested positive. Of those, the majority were asymptomatic. “Had we not discovered this in time,” Prof. Rotstein explained, “it would have paralyzed the hospital.” Prof. Rotstein noted also that two people who tested negative initially were found to be positive for the coronavirus when tested a second time.

Addressing the morale of Hadassah’s health care teams, Prof. Rotstein said that “our health care workers feel cared for because Hadassah is testing them to protect them. We are also giving them personal protective equipment (PPE).” Prof. Rotstein related that “there is no shortage of protective gear, partly thanks to the help of Alibaba, which sent PPE from China. He also noted that the absentee rate among the staff has dropped substantially.

As for the patients, Prof. Rotstein reported that all are being presented with a gift packet of masks, gloves, and hand sanitizer.

Research is in progress at Hadassah to find effective treatments for coronavirus patients, Prof. Rotstein reported. For example, Avigan, manufactured by the Japanese company Fujifilm and proven effective in helping some COVID-19 patients in Japan, is being tested on severely ill coronavirus patients at Hadassah through a scientifically conducted clinical trial.

The hospital is also accumulating and analyzing antibodies from coronavirus patients who have recovered. The goal is to give these antibodies, via a plasma infusion, to severely ill coronavirus patients. SEE UPDATE ABOUT THIS NEW CLINICAL TRIAL.

“Hadassah to Launch Clinical Trials of a Serum to Fight COVID-19.”

In addition to its innovations within the hospital setting, Hadassah has been going into the community, Prof. Rotstein said, to test residents in densely populated neighborhoods and in nursing homes (what he has designated as “red areas”). Prof. Rotstein said that 30 percent of the people in those areas tested positive for the coronavirus. This contrasts with the rate in “green areas,” where only one person per thousand tested positive.

“We are one motivated team!” Prof. Rotstein said.

Related Stories

alt_text

Tuesday, Jan 12 2021

Hadassah Speedily Vaccinates Its Staff Against COVID-19

As of January 11, out of the 6,500 individuals who work at the Hadassah Medical Organization, 4,800 had received their first dose of the Pfizer vaccine, and 1,000 had received the second dose.

READ MORE ›
alt_text

Tuesday, Jan 5 2021

Mary, From Bethlehem, Experiences Personal Christmas Miracle at Hadassah

Christmas Eve is always a special time for Mary A, an 86-year-old resident of Bethlehem.

READ MORE ›
alt_text

Tuesday, Dec 29 2020

Nurses Inject Hope at Hadassah Hospital Ein Kerem

The sun has just come up. It is 6 am and 18 pairs of eyes are staring at two Hadassah Hospital Ein Kerem nurses. One nurse is seated and the other is standing over her, a needle in hand.

READ MORE ›
alt_text

Monday, Dec 21 2020

Hadassah Collaborates to Develop a Face Mask that Kills the Coronavirus

The Hadassah Medical Organization, the Israel Institute for Biological Research (IIBR) and Tera Novel, an Israeli start-up company, have collaboratively developed an innovative antiviral and antibacterial mask...

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Israel Travel

israeltravel@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

More ›

Show More